Roberto Collado‐Borrell

620 total citations
43 papers, 392 citations indexed

About

Roberto Collado‐Borrell is a scholar working on Oncology, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roberto Collado‐Borrell has authored 43 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in General Health Professions and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roberto Collado‐Borrell's work include Mobile Health and mHealth Applications (10 papers), Medication Adherence and Compliance (6 papers) and Cancer Treatment and Pharmacology (6 papers). Roberto Collado‐Borrell is often cited by papers focused on Mobile Health and mHealth Applications (10 papers), Medication Adherence and Compliance (6 papers) and Cancer Treatment and Pharmacology (6 papers). Roberto Collado‐Borrell collaborates with scholars based in Spain, Argentina and Greece. Roberto Collado‐Borrell's co-authors include Vicente Escudero‐Vilaplana, María Sanjurjo‐Sáez, Ana Herranz‐Alonso, Rosa Romero‐Jiménez, Irene Iglesias Peinado, Eva González-Haba, Antonio Calles, Jóse Ángel Arranz Arija, Maite Martín-Conde and Ana Herranz and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Journal of Medical Internet Research.

In The Last Decade

Roberto Collado‐Borrell

41 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Collado‐Borrell Spain 11 160 98 68 55 54 43 392
Bas van Vlijmen Netherlands 7 186 1.2× 30 0.3× 59 0.9× 20 0.4× 19 0.4× 14 557
Victoria Hardy United States 11 218 1.4× 17 0.2× 39 0.6× 29 0.5× 30 0.6× 33 509
Mara Pereira Guerreiro Portugal 10 105 0.7× 88 0.9× 35 0.5× 32 0.6× 6 0.1× 45 546
Jillian Oderkirk France 10 141 0.9× 35 0.4× 18 0.3× 16 0.3× 19 0.4× 13 485
Jonathan Willner United States 13 220 1.4× 22 0.2× 45 0.7× 67 1.2× 37 0.7× 33 872
Min Soon Kim United States 9 194 1.2× 23 0.2× 19 0.3× 21 0.4× 10 0.2× 24 458
Stephen F. Rothemich United States 12 304 1.9× 143 1.5× 56 0.8× 65 1.2× 15 0.3× 14 655
Georges Adunlin United States 11 67 0.4× 137 1.4× 18 0.3× 17 0.3× 4 0.1× 25 367
Fallon Chipidza United States 9 108 0.7× 52 0.5× 12 0.2× 71 1.3× 4 0.1× 21 363
Harley Z. Ramelson United States 14 138 0.9× 17 0.2× 60 0.9× 17 0.3× 7 0.1× 24 620

Countries citing papers authored by Roberto Collado‐Borrell

Since Specialization
Citations

This map shows the geographic impact of Roberto Collado‐Borrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Collado‐Borrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Collado‐Borrell more than expected).

Fields of papers citing papers by Roberto Collado‐Borrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Collado‐Borrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Collado‐Borrell. The network helps show where Roberto Collado‐Borrell may publish in the future.

Co-authorship network of co-authors of Roberto Collado‐Borrell

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Collado‐Borrell. A scholar is included among the top collaborators of Roberto Collado‐Borrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Collado‐Borrell. Roberto Collado‐Borrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez‐Centurión, Ignacio, José Manuel García‐Domínguez, Vicente Escudero‐Vilaplana, et al.. (2025). ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling. Bone Marrow Transplantation. 60(10). 1351–1360. 2 indexed citations
2.
Real, Jordi, et al.. (2024). Validation of a Questionnaire to Assess the Usability of and User Experience with Mobile Health Applications. Healthcare. 12(23). 2328–2328. 2 indexed citations
3.
Castro, Javier de, Amelia Insa, Roberto Collado‐Borrell, et al.. (2023). Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain. BMC Pulmonary Medicine. 23(1). 69–69. 6 indexed citations
4.
Escudero‐Vilaplana, Vicente, et al.. (2022). Possible heart failure caused by osimertinib in a lung cancer patient. Journal of Oncology Pharmacy Practice. 29(4). 1015–1020. 4 indexed citations
5.
Collado‐Borrell, Roberto, Vicente Escudero‐Vilaplana, Eva González-Haba, et al.. (2022). A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital. Frontiers in Public Health. 10. 978783–978783. 2 indexed citations
6.
Escudero‐Vilaplana, Vicente, Roberto Collado‐Borrell, Lucía González‐Cortijo, et al.. (2022). Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer. Frontiers in Oncology. 12. 885910–885910. 5 indexed citations
7.
Collado‐Borrell, Roberto, Eva González-Haba, Vicente Escudero‐Vilaplana, et al.. (2022). A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application. Frontiers in Oncology. 12. 889575–889575. 2 indexed citations
8.
Escudero‐Vilaplana, Vicente, et al.. (2021). Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale. JMIR mhealth and uhealth. 10(2). e32826–e32826. 13 indexed citations
9.
Escudero‐Vilaplana, Vicente, et al.. (2021). Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study. International Journal of Environmental Research and Public Health. 18(2). 394–394. 5 indexed citations
10.
Escudero‐Vilaplana, Vicente, et al.. (2021). Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective. Frontiers in Oncology. 11. 636068–636068. 17 indexed citations
11.
Collado‐Borrell, Roberto, Vicente Escudero‐Vilaplana, Maite Martín-Conde, et al.. (2020). Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study. JMIR mhealth and uhealth. 8(10). e20480–e20480. 12 indexed citations
12.
Escudero‐Vilaplana, Vicente, Roberto Collado‐Borrell, Ricardo González del Val, et al.. (2020). Aggressiveness of end-of-life cancer care: what happens in clinical practice?. Supportive Care in Cancer. 29(6). 3121–3127. 5 indexed citations
13.
Collado‐Borrell, Roberto, et al.. (2020). Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis. Journal of Medical Internet Research. 22(8). e20334–e20334. 64 indexed citations
14.
Escudero‐Vilaplana, Vicente, Antonio Calles, Roberto Collado‐Borrell, et al.. (2020). Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting. Frontiers in Oncology. 10. 1645–1645. 7 indexed citations
15.
Collado‐Borrell, Roberto, et al.. (2020). Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis. JMIR mhealth and uhealth. 8(7). e17609–e17609. 32 indexed citations
16.
Escudero‐Vilaplana, Vicente, Rebeca Bailén, Roberto Collado‐Borrell, et al.. (2020). Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease. Journal of Oncology Pharmacy Practice. 27(3). 751–755. 6 indexed citations
17.
Romero‐Jiménez, Rosa, et al.. (2018). 5PSQ-078 Secukinumab for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in clinical practice. HighWire Press Open Archive. A200.2–A201. 1 indexed citations
18.
Collado‐Borrell, Roberto, Vicente Escudero‐Vilaplana, Rosa Romero‐Jiménez, et al.. (2016). Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account. Journal of Cancer Research and Clinical Oncology. 142(11). 2319–2330. 36 indexed citations
19.
Collado‐Borrell, Roberto, et al.. (2016). Smartphone applications for cancer patients; what we know about them?. SHILAP Revista de lepidopterología. 40(1). 25–35. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bas van Vlijmen Breakdown of academic impact, for papers by Victoria Hardy Breakdown of academic impact, for papers by Mara Pereira Guerreiro Breakdown of academic impact, for papers by Jillian Oderkirk Breakdown of academic impact, for papers by Jonathan Willner Breakdown of academic impact, for papers by Min Soon Kim Breakdown of academic impact, for papers by Stephen F. Rothemich Breakdown of academic impact, for papers by Georges Adunlin Breakdown of academic impact, for papers by Fallon Chipidza Breakdown of academic impact, for papers by Harley Z. Ramelson
Rankless by CCL
2026